Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 23, 1993 - Issue 4
7
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Rat hepatocyte-mediated metabolism of the experimental anti-tumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide

, , &
Pages 361-371 | Received 05 Dec 1991, Accepted 28 Jan 1993, Published online: 22 Sep 2008

References

  • Atwell G. J., Rewcastle G. W., Baguley B. C., Denny W. A. Potential antitumour agents. 50.In vivo solid tumour activity of derivatives ofN-[2-(dimethylamino)ethyl]acridine-4-carboxamide. Journal of Medicinal Chemistry 1987; 30: 664–669
  • Baguley B. C. Amsacrine: a new antileukaemic agent. Drugs of Today 1984; 20: 237–245
  • Berry M. N., Friend D. S. High yield preparation of isolated rat liver parenchymal cells. Journal of Cell Biology 1969; 43: 506–520
  • Buening M. K., Franklin M. R. SKF 525A inhibition, induction and 425-nm complex formation. Drug Metabolism and Disposition 1976; 4: 244–255
  • Burstyn J. N., Iskander M., Brady J. F., Fukuto J. M., Cho A. K. Comparative studies ofN-hydroxylation andN-demethylation by microsomal cytochrome P-450. Chemical Research in Toxicology 1991; 4: 70–76
  • Finlay G. J., Baguley B. C. Selectivity ofN-[2-(dimethylamino)ethyl]acridine-4-carboxamide towards Lewis lung carcinoma and human tumour cell linesin vitro. European Journal of Cancer and Clinical Oncology 1989; 25: 271–277
  • Kitamura S., Tatsumi K. Reduction of tertiary amineN-oxides by liver preparations: function of aldehyde oxidase as a majorN-oxide reductase. Biochemical and Biophysical Research Communication 1984; 121: 749–754
  • Kukongviriyapan V., Stacey N. H. Inhibition of taurocholate transport by cyclosporin A in cultured rat hepatocytes. Journal of Pharmacology and Experimental Therapeutics 1988; 247(2)685–689
  • Marshall B., Ralph R. K. Reassessment of the mechanism of action of 4′-[(9-acridinyl)-amino]methanesulphon-m-anisidide. European Journal of Cancer and Clinical Oncology 1982; 18: 553–557
  • Marshall B., Ralph R. K. The mechanism of action ofmAMSA. Advances in Cancer Research 1985; 44: 267–293
  • Palmer B. D., Rewcastle G. W., Atwell G. J., Baguley B. C., Denny W. A. Potential antitumour agents. 54. Chromophore requirements for in vivo antitumour activity among the general class of linear tricylic carboxamides. Journal of Medicinal Chemistry 1988; 31: 707–712
  • Paxton J. W., Young D., Evans S. M. H., Kestell P., Robertson I. G. C., Cornford E. M. Disposition and toxicity of the antitumour agentN-[2-dimethylamino)ethyl]acridine-4-carboxamide in the mouse. Cancer Chemotherapy and Pharmacology 1992; 29: 379–384
  • Robertson I. G. C., Palmer B. D., Officer M., Siegers D. J., Paxton J. W., Shaw G. J. Cytosol mediated metabolism of the experimental antitumour agent acridine carboxamide to the 9-acridone derivative. Biochemical Pharmacology 1991; 42: 1879–1884
  • Robertson I. G. C., Palmer B. D., Paxton J. W., Bland T. J. Metabolism of the experimental antitumour agent acridine carboxamide (AC) in the mouse. Drug Metabolism and Disposition 1993, (in press)
  • Ross W. E. DNA topoisomerase as targets for cancer therapy. Biochemical Pharmacology 1985; 34: 4191–4195
  • Schwarze P. E., Petterson E. O., Seglen P. O. Characterization of hepatocytes from carcinogen-treated rats by two-parametric flow cytometry. Carcinogenesis 1986; 7: 171–173
  • Tyson C. A., Green C. E. Cytotoxicity measures, choices and methods. The Isolated Hepatocyte: Use in Toxicity and Xenobiotic Biotransformation, E. J. Rauckman, G. M. Padilla. Academic Press, New York 1987; 119–151
  • Yamada H., Baba T., Hirata Y., Oguri K., Yoshimura H. Studies onN-demethylation of methamphetamine by liver microsomes of guine? pigs and rats: the role of flavin-containing mono-oxygenase and cytochrome P-450 systems. Xenobiotica 1984; 14: 861–866

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.